China (Mainland)
Assessedsupplier 
N-(Azido-PEG3)-N-Boc-PEG4-NHS ester CAS NO.2112731-96-9
- Min.Order: 0
- Payment Terms:
- Product Details
Keywords
- 2112731-96-9
- N-(Azido-PEG3)-N-Boc-PEG4-NHS ester
Quick Details
- ProName: N-(Azido-PEG3)-N-Boc-PEG4-NHS ester
- CasNo: 2112731-96-9
- Molecular Formula: C28H49N5O13
- Appearance: White powder
- Application: Used in producing API
- DeliveryTime: 2 weeks
- PackAge: Aluminum bag/Carton Drum
- Port: Shanghai
- Purity: NLT 98%
- Storage: Store in a tightly closed container, i...
- Transportation: By air
- LimitNum: 0
- Moisture Content: 0.005
- Impurity: NMT1%
Superiority
We Huarong Pharm can provide Customized Synthesis & Process R&D & APIs and intermediates Production & Quality Research & Registration Application, especially our GMP validation service which complies with SFDA, FDA, WHO and EU EMPA.
Our Excellent RA Team could help you easlily to register our products in different countries. If you and your customer are interested in some products or need CMO business service because of capacity limit, product cost limit or developing limit, plz feel free to contact
Besides, we could discuss the possible FDF distribution business. Hope to get the chance to discuss deeply.
Details
Hangzhou Huarong Pharm Co., Ltd. established since 2009 , has been always focusing on supplying products and services to our clients in the field of small molecule drug.
Huarong Pharm has built platforms for the research, development and manufacturing of Building Blocks, Reference Compounds & Impurities, Natural products, APIs & Intermediates, Antibody-drug Conjugates (ADCs) and others. To maintain a high innovation efficiency, the company has continuously increased the investment on R&D facilities and state-of-the-art equipment in the past several years, including the establishment of kilogram GMP conditions plants and R&D centers.
Huarong Pharm adheres to our vision, our mission, and our value, keeping abreast of the current trend and state-of-the-art science and technologies of the global biopharmaceutical industry to serve our clients to the utmost satisfaction. Our existing advantages have led to our in-depth services for the R&D of small molecule drug discovery.
At present, Huarong Pharm has successfully delivered innovative R&D products and services to more than 3,000 partners across the world. Our goal is to become a world-class leading company to support life science innovation and manufacturing.
Huarong Pharm has built platforms for the research, development and manufacturing of Building Blocks, Reference Compounds & Impurities, Natural products, APIs & Intermediates, Antibody-drug Conjugates (ADCs) and others. To maintain a high innovation efficiency, the company has continuously increased the investment on R&D facilities and state-of-the-art equipment in the past several years, including the establishment of kilogram GMP conditions plants and R&D centers.
Huarong Pharm adheres to our vision, our mission, and our value, keeping abreast of the current trend and state-of-the-art science and technologies of the global biopharmaceutical industry to serve our clients to the utmost satisfaction. Our existing advantages have led to our in-depth services for the R&D of small molecule drug discovery.
At present, Huarong Pharm has successfully delivered innovative R&D products and services to more than 3,000 partners across the world. Our goal is to become a world-class leading company to support life science innovation and manufacturing.